MADRYN ASSET MANAGEMENT, LP
MADRYN ASSET MANAGEMENT, LP is a Series C+ fund in the US, Western Europe and Asia-Pacific writing $20M–$75M checks into biopharmaceuticals, medical-devices, diagnostics, life-sciences and healthcare-it.
- Stages
- Series C+
- Sectors
- biopharmaceuticals, medical-devices, diagnostics, life-sciences, healthcare-it
- Check size
- $20M–$75M
- Invests in
- US-wide, Western Europe, Asia-Pacific
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $915M
- Website
- madrynlp.com
Thesis
Madryn Asset Management, LP is a New York-based alternative asset manager founded in 2017, focusing on providing long-term capital to innovative healthcare companies across biopharmaceuticals, medical devices, diagnostics, life sciences, and healthcare IT. Their investment thesis targets commercial-stage companies with scalable products and strong IP, aiming to capitalize on healthcare market inefficiencies. Madryn's strategy is global, with a primary focus on North America, Western Europe, and Asia-Pacific. They predominantly offer customized financing solutions, with approximately 85% in private debt (senior, subordinated, convertible) and 15% in equity, often combined with debt. They also engage in revenue interests, royalty streams, and selective equity. Madryn typically invests $20M-$75M per deal, aiming to support companies that may not qualify for traditional bank financing or wish to avoid equity dilution. As of December 31, 2025, AUM was $915M. The firm is a signatory to the UN-supported Principles for Responsible Investing (PRI) and incorporates ESG considerations.
Common questions
Does MADRYN ASSET MANAGEMENT, LP invest at the Series C+ stage?
Yes. MADRYN ASSET MANAGEMENT, LP lists Series C+ among the stages it invests in.
What check size does MADRYN ASSET MANAGEMENT, LP write?
MADRYN ASSET MANAGEMENT, LP writes $20M–$75M checks.
Where does MADRYN ASSET MANAGEMENT, LP invest?
MADRYN ASSET MANAGEMENT, LP invests in the US, Western Europe and Asia-Pacific.